Biotechnology - Patents

Filter

Current filters:

Patents

Popular Filters

1 to 25 of 77 results

Biotech clusters with patent strategies are more attractive to big pharma

Biotech clusters with patent strategies are more attractive to big pharma

01-07-2014

Life sciences and biotech research clusters across the UK are benefiting from an improved funding climate…

BiotechnologyFinancialPatentsUK

BioTime's subsidiary Asterias settles patent interference proceedings with ViaCyte

29-05-2014

US biotech firm BioTime says its subsidiary Asterias Biotherapeutics has entered into a settlement agreement…

Asterias BiotherapeuticsBiotechnologyBioTimeLegalPatentsUSAViaCyte

Joint position to grow Australia's biopharmaceutical industry

Joint position to grow Australia's biopharmaceutical industry

29-05-2014

Trade groups AusBiotech and Medicines Australia this morning published a joint statement sent to the…

AustraliaBiotechnologyFinancialMarkets & MarketingPatentsPharmaceuticalResearch

India’s bio-pharma market forecast to reach $7 billion by FY2015

08-05-2014

Growing at an average rate of about 20%, India’s biotech industry comprising bio-pharmaceuticals, bio-services,…

BiotechnologyIndiaMarkets & MarketingPatentsResearch

Australian government plans no action on Pharmaceutical Patent Review

Australian government plans no action on Pharmaceutical Patent Review

27-03-2014

The Australian federal government last week released a statement on the Pharmaceutical Patent Review…

Asia-PacificAustraliaBiotechnologyPatentsResearch

Proposed new bill would create new patent term extension for certain biologics patents in USA

Proposed new bill would create new patent term extension for certain biologics patents in USA

26-03-2014

Earlier this week in the USA, legislation was introduced allowing new sponsors to gain intellectual property…

BiotechnologyLegalNorth AmericaPatentsPoliticsUSA

Idenix Pharma files law suits against Gilead in Europe over sofosbuvir

Idenix Pharma files law suits against Gilead in Europe over sofosbuvir

14-03-2014

US drugmaker Idenix Pharmaceuticals says it has filed patent infringement law suits against biotech firm…

Anti-viralsBiotechnologyGilead SciencesIdenix PharmaceuticalsLegalNorthern EuropePatentssofosbuvirSovaldi

Asia-Pacific region sees boom in Biotech investment

Asia-Pacific region sees boom in Biotech investment

07-03-2014

The Asia-Pacific (APAC) region is experiencing a significant boom in the volume of private equity (PE)…

Asia-PacificBiotechnologyFinancialPatents

Amarin files suit against AstraZeneca over Epanova

Amarin files suit against AstraZeneca over Epanova

05-03-2014

US biotech firm Amarin revealed in a Stock Exchange Commission submission that it has filed a complaint…

AmarinAstraZenecaBiotechnologyCardio-vascularEpanovaLegalNorth AmericaOmthera PharmaceuticalsPatentsUSAVascepa

USA’s BIO expresses serious concerns on Innovation Act, HR 3309

04-12-2013

The US trade group Biotechnology Industry Organization (BIO) has expressed grave concerns relating to…

BiotechnologyLegalNorth AmericaPatentsPolitics

Biogen prevails in EU exclusivity battle for MS drug Tecfidera

Biogen prevails in EU exclusivity battle for MS drug Tecfidera

25-11-2013

US biotech company Biogen Idec saw its shares leap 10% to an all-time high of nearly $278 on Friday,…

Biogen IdecBiotechnologyEuropeNeurologicalPatentsRegulationTecfidera

I-MAK challenges Gilead sofosbuvir patent in India

I-MAK challenges Gilead sofosbuvir patent in India

25-11-2013

USA-based advocacy group the Initiative for Medicines, Access & Knowledge last week filed a challenge…

Anti-viralsAsia-PacificBiotechnologyGilead SciencesPatentssofosbuvirSovaldi

AusBiotech joins forces with Cook Medical and Deloitte on tax

27-09-2013

Australian biotechnology industry experts are joining forces to support a “patent box” tax incentive,…

Asia-PacificBiotechnologyFinancialPatentsResearch

Plasma Tech claims patent for its product will shake up plasma biopharma market

11-09-2013

Privately-held US firm Plasma Technologies announced the recent issuance of US patent No 8,293,242, an…

BiotechnologyPatentsPlasma Technologies

US Court denies re-hearing of Arzerra patent case

16-07-2013

Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

US Supreme Court issues mixed ruling on DNA patents

14-06-2013

The US Supreme Court yesterday (June 13) delivered its unanimous decision regarding the Association for…

BiotechnologyGeneticsLegalMyriad GeneticsNorth AmericaPatents

Ockham Biotech prevails in Vectura's patent challenge for inhaled heparin in COPD

03-06-2013

UK-based Ockham Biotech says that its European patent covering the use of inhaled heparin for the treatment…

BiotechnologyEuropeheparinOckham BiotechPatentsRespiratory and PulmonaryVectura

Market access barriers for multinationals, but Argentina still offers attractive pharma opportunities

31-05-2013

Several barriers impede market access but the regulatory landscape in Argentina is changing and attractive…

BiotechnologyMarkets & MarketingPatentsPharmaceuticalRegulationSouth America

Biogen Idec sees EU launch delay for Tecfidera on patent issues

31-05-2013

In a filing with the Securities and Exchange Commission, US biotech firm Biogen Idec (Nasdaq: BIIB) said…

Biogen IdecBiotechnologyEuropeMarkets & MarketingNeurologicalPatentsRegulationTecfidera

Myriad Genetics' gene patenting battle: BRACAnalysis won't suffer the consequences, says GlobalData analyst

09-05-2013

USA-based Myriad Genetics (Nasdaq: MYGN) is currently disputing its right to claim ownership to a human…

BiotechnologyEuropeMyriad GeneticsNorth AmericaPatents

AusBiotech expresses concern over plan to remove or limit patent extensions

02-05-2013

Trade association AusBiotech has made a submission in response to the Australian Pharmaceutical Patent…

Asia-PacificBiotechnologyPatentsPolitics

1 to 25 of 77 results

Back to top